Core Viewpoint - The resignation of Mr. Li Ning as Vice President of Shenzhen BGI Genomics Co., Ltd. is due to work arrangement reasons, but he will continue to serve as a director of the company and hold positions in its subsidiaries [2][3]. Summary by Sections Resignation Details - Mr. Li Ning's resignation as Vice President is effective immediately upon the board's receipt of his resignation report, and he will maintain his role as a director [2][3]. - His original term as a senior executive was from June 18, 2024, to June 17, 2027 [3]. Shareholding Information - As of the announcement date, Mr. Li holds 122,600 shares directly and has 1,037,880 shares through the company's second employee stock ownership plan [3]. - His associates do not hold any shares in the company [3]. Compliance and Transition - Mr. Li has completed the necessary work handover in accordance with the company's regulations, ensuring that his resignation will not affect the company's daily operations and management [4]. - The board expressed gratitude for Mr. Li's contributions during his tenure [4].
李宁辞去生命科学仪器企业副总经理职位